Blockbuster! ZhengChuan second medium boron kiln ignition put into operation
the second medium boron kiln ignition to achieve the independent design and construction
On July 29, ZhengChuan hold the ignition ceremony of the second medium boron kiln, the company's park leadership, ZhengChuan company chairman Deng Yong, China biochemical pharmaceutical association, Chinese Vaccine Association, customer representative qilu pharmaceutical, Kexing Zhongwei, etc, Speeched in turn.The conference also invited more than 80 domestic large and medium-sized pharmaceutical companies chairman of the general manager and relevant responsible persons to witness this important moment.
The fire of hope was lit, and the crowed cheered and clapped.
Deng Yong, chairman of Zhengchuan, said that the successful ignition of the second boron kiln is another important milestone for Zhengchuan. Zhengchuan has been committed to research, development and production of pharmaceutical glass packaging materials for more than 30 years since its establishment, and has formed a highly integrated production of "tube drawing, bottle making and cap making".
It is reported that The second medium boron kiln was designed and built by ZhengChaun on the basis of digesting and absorbing the first imported medium boron kiln.This kiln has optimized the key structural design, and adopted the "full oxygen combustion + electric fusion" temperature control system, platinum heating and other advanced boron technologies.The application of these technologies will not only further the quality of the boric tube, but also realize self-control of the technoligy.
In recent years, in order to promote the development of transformation and upgrading, Zhengchuan started the special research project of borosilicate glass production technology. In the Boron tube, Boron bottle, product and market structure upgrading innovation.
Chairman Deng Yong also described the future development blueprint of Zhengchuan, which will accelerate the overall layout of boron product market, deepen the layout of high-end product market, and actively promote the construction of prefilled syringe project. It is foreseeable that the completion of the project will further improve the product market coverage, comprehensively enhance the enterprise's market competitiveness and comprehensive profitability.
the performance of the first boron kiln reached the production standard
At present, the enterprises that produce high quality boron silicate glass bottles are still not many. Relevant date statistics, our country is engaged in officinal glass packaging enterprises more than 60 only.
It is worth mentioning that the production process of Chinese boron glass tubes in China is also very short, but mastering mature mass production technology has always been the pursuit of domestic pharmaceutical packaging enterprises.
As one of the leading enterprises in the domestic pharmaceutical glass bottle subdivision industry, ZhengChuan pharmaceutical packaging material company completed the construction of its the first boron kiln and put it into operation on October 27, 2020, less than a year and a half ago.
Now, The first medium boron kiln has achieved full production and efficiency, with a cumulative production of nearly 6000 tons of glass tubes.
ZhengChuan power promote the progress of the industry
As one of the largest enterprises in the field of pharmaceutical glass, Zhengchuan Corporation has established a relatively perfect technological innovation system under the continuous strengthening of R&D investment in pharmaceutical "pipe-pulling, bottle-making and lid-making".
The 2021 performance report shows that it has 31 patented technologies, including 2 invention patents. At the same time, it has trained a number of outstanding technical talents in the industry, so that it has a strong talent reserve and continuous innovation power.
Zhengchuan has more than 1000 controlled bottle production lines, with an annual output of more than 10 billion controlled glass bottles, and is one of the world's largest manufacturers in the regulated bottle segment industry. It has imported automatic vial production line, imported automatic ampoule bottle production line, domestic high-precision bottle production line; Also has passed the national "CNAS certification" laboratory, with pharmaceutical glass ingredients, physical and chemical properties.
At the same time, the self-produced "Chinese boron pull tube - Chinese boron bottle" has realized the integrated scale, and the production capacity and technical level of Chinese boron products have reached the industry leading level, which can fully meet the market demand of Chinese boron product incremental and high-end packaging materials such as vaccines and biological products under the consistency evaluation.
Deng Qiuhan, deputy general manager of Zhengchuan Stock, said that in the next five years, we will continue to concentrate on the business map of Chinese pharmaceutical packaging materials, and strive to do fully. The future planning will be based on the core business diversification, sales and service improvement, compatibility service upgrade, cost-effective building, new product exploration five areas.
In the control bottle related core business, the future plan to build 8 boron kiln, to achieve the capacity of 50,000 tons of boron glass pipe; The total production capacity of controlled bottles exceeded 15 billion, including 4 billion medium boron injection bottles, 3 billion medium boron ampoules, and 1 billion pre-filling syringes. 5 billion medicinal bottle caps, among which the annual production of 3 billion disposable medical bottle caps, and will actively expand the new series of disposable medical glass bottles.
ZhengChuan has always been the long-term innovation and development of pharmaceutical glass, promote the industry progress.
